Screening of neuropathic pain components in patients with chronic back pain associated with nerve root compression: a prospective observational pilot study (MIPORT)
- PMID: 16574036
- DOI: 10.1185/030079906X89874
Screening of neuropathic pain components in patients with chronic back pain associated with nerve root compression: a prospective observational pilot study (MIPORT)
Abstract
Objective: Chronic back pain is characterized by a combination of neuropathic and nociceptive mechanisms of pain generation. The prevalence of the neuropathic pain component is unknown. Thus, in the context of an explorative study, we aimed to determine the prevalence of signs and symptoms indicating neuropathic pain in adult patients treated by orthopaedists. We also aimed to assess the usefulness of handheld computers (PDAs) in data collection.
Methods: Prospective epidemiological study in 18 orthopaedic practices or centres throughout Germany. Physician and patient questionnaires (paper/pencil or on handheld computers, PDAs) for patients with back pain of at least 3 months in duration were applied, as well as the von Korff score to assess pain intensity (visual analogue scale, VAS; 0 = no pain, 10 = worst possible pain) and pain characteristics, the Hannover Functional Ability Questionnaire (FFbH-R), and if patients agreed to provide information, the short-form Patient Health Questionnaire (PHQ-D) for depression.
Results: For 717 patients, both patient and physician questionnaires were available. Mean patient age was 56 years; pain was predominantly located in the low back (87%). Median current pain intensity on the VAS was 5.0. Confirmed key signs and symptoms indicated neuropathic pain was frequent, e.g. radicular pain radiating beyond the knee towards the foot (40.0%), positive Lasegue sign (18.4%), or absent patellar reflex (17.3%). A third of all patients (33.5%) had >or=3 characteristic signs for neuropathic pain. Patient functionality was severely reduced (median 43.3%). There were no relevant differences in outcomes between patients using the paper/pencil method (47%) versus those preferring PDAs (53%).
Conclusion: Screening for neuropathic pain in this setting is feasible with simple questionnaires and scales on PDAs. Neuropathic pain is a major contributor to chronic back pain and a frequent component in patients seen by orthopaedists. At least one third of all patients should undergo additional diagnostic measures to confirm the cause of neuropathic pain.
Similar articles
-
painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain.Curr Med Res Opin. 2006 Oct;22(10):1911-20. doi: 10.1185/030079906X132488. Curr Med Res Opin. 2006. PMID: 17022849
-
Prevalence of neuropathic pain among patients suffering from chronic low back pain in Saudi Arabia.Saudi Med J. 2004 Dec;25(12):1986-90. Saudi Med J. 2004. PMID: 15711681
-
The neuropathic components of chronic low back pain: a prospective multicenter study using the DN4 Questionnaire.J Pain. 2011 Oct;12(10):1080-7. doi: 10.1016/j.jpain.2011.05.006. Epub 2011 Jul 23. J Pain. 2011. PMID: 21783428
-
What is the evidence that neuropathic pain is present in chronic low back pain and soft tissue syndromes? An evidence-based structured review.Pain Med. 2014 Jan;15(1):4-15. doi: 10.1111/pme.12229. Epub 2013 Oct 4. Pain Med. 2014. PMID: 24118776 Review.
-
Neuropathic pain and its assessment.Surg Oncol. 2010 Sep;19(3):149-54. doi: 10.1016/j.suronc.2009.11.012. Epub 2010 Jan 6. Surg Oncol. 2010. PMID: 20056406 Review.
Cited by
-
Axial low back pain: one painful area--many perceptions and mechanisms.PLoS One. 2013 Jul 2;8(7):e68273. doi: 10.1371/journal.pone.0068273. Print 2013. PLoS One. 2013. PMID: 23844179 Free PMC article.
-
Validity and reliability of the Spanish version of the DN4 (Douleur Neuropathique 4 questions) questionnaire for differential diagnosis of pain syndromes associated to a neuropathic or somatic component.Health Qual Life Outcomes. 2007 Dec 4;5:66. doi: 10.1186/1477-7525-5-66. Health Qual Life Outcomes. 2007. PMID: 18053212 Free PMC article.
-
Cebranopadol, a novel first-in-class analgesic drug candidate: first experience in patients with chronic low back pain in a randomized clinical trial.Pain. 2017 Sep;158(9):1813-1824. doi: 10.1097/j.pain.0000000000000986. Pain. 2017. PMID: 28644196 Free PMC article. Clinical Trial.
-
Improvement in predominant back pain following minimally invasive decompression for spinal stenosis.J Neurosurg Spine. 2023 Jul 14;39(4):576-582. doi: 10.3171/2023.5.SPINE23278. Print 2023 Oct 1. J Neurosurg Spine. 2023. PMID: 37486867 Free PMC article.
-
Gut microbiota regulates neuropathic pain: potential mechanisms and therapeutic strategy.J Headache Pain. 2020 Aug 17;21(1):103. doi: 10.1186/s10194-020-01170-x. J Headache Pain. 2020. PMID: 32807072 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical